16 . December , 2018 - Sunday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Hydrocortisone

Big Image
Generic Name: Hydrocortisone
Dosage Form: Cream usp, 1%

Rx only

For External Use Only

Not For Ophthalmic Use

Hydrocortisone Description

Hydrocortisone Cream USP, 1% contains Hydrocortisone [pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11ß)-], with the molecular formula C21H30O5 and molecular weight 362.47. Each gram contains 10 mg of Hydrocortisone in a base containing glyceryl monostearate, polyoxyl 40 stearate, glycerin, paraffin, stearyl alcohol, isopropyl palmitate, sorbitan monostearate, benzyl alcohol, potassium sorbate, lactic acid, and purified water.

Hydrocortisone - Clinical Pharmacology

Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.

Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses. (See DOSAGE AND ADMINISTRATION). Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and then are excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted by the bile.

Indications and Usage for Hydrocortisone

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Precautions

General: Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid. Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids. Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See PRECAUTIONS-Pediatric Use). If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted. In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.

Information for the Patient: Patients using topical corticosteroids should receive the following information and instructions:

  1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.
  2. Patients should be advised not to use this medication for any disorder other than for which it was prescribed.
  3. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician.
  4. Patients should report any signs of local adverse reactions especially under occlusive dressing.
  5. Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.

Laboratory Tests: The following tests may be helpful in evaluating the HPA axis suppression: Urinary free cortisol test; ACTH stimulation test.

Carcinogenesis, Mutagenesis, and Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect on fertility of topical corticosteroids. Studies to determine mutagenicity with prednisolone and Hydrocortisone have revealed negative results.

Pregnancy:Teratogenic effects- Pregnancy Category C. Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Nursing Mothers: It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Pediatric Use:Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Overdosage

Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (See PRECAUTIONS).

Hydrocortisone Dosage and Administration

Topical corticosteroids are generally applied to the affected area as a thin film two or three times a day depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

How is Hydrocortisone Supplied

Hydrocortisone Cream USP, 1%, a white cream, is supplied as follows:

NDC 0168-0015-31 28.35 g (1 Oz) tubes
NDC 0168-0015-16 453.6 g (1 lb) jars

Store at controlled room temperature 15°-30°C (59°-86°F).

E. FOUGERA & CO
a division of Altana Inc.
MELVILLE, NEW YORK 11747
www.fougera.com

I21531E/IF21504E
R1/00
#190


Hydrocortisone (Hydrocortisone)
PRODUCT INFO
Product Code 0168-0015 Dosage Form CREAM
Route Of Administration TOPICAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Hydrocortisone (Hydrocortisone) Active 10 MILLIGRAM  In 1 MILLIGRAM
glyceryl monostearate Inactive  
polyoxyl 40 stearate Inactive  
glycerin Inactive  
paraffin Inactive  
stearyl alcohol Inactive  
isopropyl palmitate Inactive  
sorbitan monostearate Inactive  
benzyl alcohol Inactive  
potassium sorbate Inactive  
lactic acid Inactive  
water Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0168-0015-31 28.35 GRAM In 1 TUBE None
2 0168-0015-16 453.6 GRAM In 1 JAR None

Revised: 06/2006

Recent Drug Updates at DrugIndexOnline:





Anthranol 0.4 Topical Anthranol 0.4 Topical
Some commonly used brand names are: In the U.S.— Drithocreme Drithocreme HP Dritho-Scalp Micanol In Canada— Anthraforte 1 Anthraforte 2 Anthranol 0.1 Anthranol 0.2 Anthranol 0.4 Anthrascalp Another commonly used name is dithranol . Category Antipsoriatic, topical Hair growth more...

Aredia Aredia
Generic Name: pamidronate (pah MIH droe nate) Brand Names: Aredia What is Aredia (pamidronate)? Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels o more...

Aureomycin Topical Aureomycin Topical
Some commonly used brand names are: In the U.S.— Aureomycin 1 Achromycin 3 Meclan 2 Topicycline 3 In Canada— Achromycin 3 Aureomycin 1 Note: For quick reference, the following tetracyclines are numbered to match the corresponding brand names. This information applies to more...

Chlordrine S.R. Chlordrine S.R.
Some commonly used brand names are: In the U.S.— Allerest Maximum Strength 7 Allerphed 14 Atrohist Pediatric 7 Atrohist Pediatric Suspension Dye Free 8 Benadryl Allergy Decongestant Liquid Medication 10 Brofed Liquid 3 Bromadrine TR 3 Bromfed 3 Bromfed-PD 3 Bromfenex 3 Bromfenex PD 3 Chlo more...

Chlorpheniramine/Hydrocodone Liquid Chlorpheniramine/Hydrocodone Liquid
Generic Name: Chlorpheniramine/Hydrocodone Oral Liquid (klor-fen-EER-a-meen/hye-droe-KOE-done) Brand Name: S-T Forte 2Chlorpheniramine/Hydrocodone Liquid is used for:Treating symptoms of the common cold, flu, or hayfever, and other upper respiratory allergies such as cough, runny nose, sneezing, more...

Cytovene Cytovene
Generic Name: Ganciclovir Injection (gan-SYE-kloe-vir) Brand Name: CytoveneCytovene may cause low white blood cell levels, low platelet levels, and anemia. In animal studies, it caused cancer, low sperm production, and birth defects. Cytovene is used to treat cytomegalovirus (CMV) eye infectio more...

Ipratropium Nasal Ipratropium Nasal
Some commonly used brand names are: In the U.S.— Atrovent In Canada— Atrovent Category Anticholinergic, nasal Description Ipratropium (i-pra-TROE-pee-um) nasal spray is used to relieve runny nose (rhinorrhea). The 0.03% nasal solution is used to relieve a runny nose assoc more...

Prednisolone Acetate/Neomycin Sulfate/Polymyxin B Sulfate Prednisolone Acetate/Neomycin Sulfate/Polymyxin B Sulfate
Pronouncation: (pred-NISS-oh-lone ASS-uh-TATE/NEE-oh-MY-sin SULL-fate/pahl-ee-MIX-in BEE SULL-fate) Class: Corticosteroid, Antibacterial Trade Names: Poly-Pred Liquifilm - Ophthalmic Suspension 0.5% prednisolone acetate/neomycin sulfate equiv. to 0.35% neomycin base/10,000 units/mL polymyxin B sulf more...